Biography

Lu Peng, MD is an associate chief physician at JiShuiTan Hospital, a teaching hospital of Beijing University School of Medicine. Dr. Peng is recognized expert in Cardiology, Internal Medicine, Clinical Research and Drug Discovery. She graduated from Beijing University School of Medicine and completed residency in Section of Cardiology, Internal Medicine, JiShuiTan Hospital. She was the visiting scholar of Ben May Institute for Cancer Research at the University of Chicago and focused on the drug discovery against metabolic diseases.

Area of Interest:

Biomedical Sciences

100%

Internal Medicine

62%

Neurosciences

90%

Metabolism

75%

Cardiology

55%

Research Publications in Numbers

Books
0

Chapters
0

Articles
0

Abstracts
0

Selected Publications

Peng, L., X.S. Zhao and J.T. Xie, 2012. Therapeutic effect of a novel liver X receptor agonist ATI-829 on diabetic mice. J. Jilin Univ., 38: 441-446.
Peng, L., S. Sun, L.H. Xie, S.M. Wicks and J.T. Xie, 2012. Ginsenoside Re: pharmacological effects on cardiovascular system. Cardiovasc. Ther., 30: 183-188.
CrossRef | Direct Link |
Peng, L., R.A. Hiipakka, J.T. Xie, J.M. Kokontis, S. Liao and D. Peng, 2011. The effect of diet on the response of low-density lipoprotein receptor knockout mice to the liver X receptor agonist T1317. J. Cardiovasc. Pharmacol., 58: 102-110.
CrossRef | Direct Link |
Peng, L., X.S. Zhao and Z. Ma, 2009. Effects of amlodipine and azelnidipine on plasma inflammatory factors hs-CRP and TIMP-1 in hypertension patients. Beijing Med., 31: 461-464.
Peng, L., Y.T. Han and J. Chen, 2007. The effects between LXR signaling pathway and inflammation in mouse primary astrocytes. Beijing Med., 29: 39-41.